RecruitingNCT05011760
Brain imaging of dopamine response in cocaine use disorder
About this title
Read the official source —Medication studyAges 18–55United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 18 years to 55 years.
- Listed locations
- PittsburghSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 31, 2021
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 30
- Sponsor
- Rajesh Narendran
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug, RADIATION
- Study phase
- EARLY Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT05011760
- Official title
Show the full official title
[C-11]NPA PET-amphetamine in Cocaine Use Disorders (Aim 2)
Recruitment & locations
RecruitingPittsburgh
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Rajesh Narendran.
Does this study involve medication?
Yes. The study involves medication, including d-amphetamine.
Who can participate?
Listed age limits: 18 years to 55 years.
Is this study still recruiting?
The registry lists this study as recruiting.
